CH-95-05-4 -- Evaluation of a Liquid Desiccant-Enhanced Heat Pipe Air Preconditioner PDF

CH-95-05-4 -- Evaluation of a Liquid Desiccant-Enhanced Heat Pipe Air Preconditioner PDF

Name:
CH-95-05-4 -- Evaluation of a Liquid Desiccant-Enhanced Heat Pipe Air Preconditioner PDF

Published Date:
1995

Status:
Active

Description:

Publisher:
ASHRAE

Document status:
Active

Format:
Electronic (PDF)

Delivery time:
10 minutes

Delivery time (for Russian version):
200 business days

SKU:

Choose Document Language:
$4.8
Need Help?

Presents the results of an experimental evaluation of enhancing the dehumidification performance of a heat pipe heat recovery unit by incorporating a liquid desiccant dehumidification function. A commercial heat pipe thermal recovery unit with an indirect evaporative cooling feature was modified by incorporating a liquid desiccant contacting/recirculation loop on the supply-air side. Two liquid desiccants, lithium chloride (LiCl) and triethylene glycol (TEG) solutions, were tested in this device. The cooling capacity of the heat pipe with desiccants increased 20% to 40%. The cooling performance of the heat pipe system using TEG was about 10% less than when using LiCl. The efficiency of the dehumidification operation was estimated to be only on the order of 40% to 50% of the equilibrium dehumidification potential because of less-than-optimum gas/liquid contact. Further research and development could improve this performance into the 80% to 90% range. The outcome suggests that the liquid-desiccant-enhanced heat pipe device could be a viable system for preconditioning ventilation air.

KEYWORDS: year 1995, calculating, desiccants, heat pipes, ventilation, dehumidifying, performance, heat recovery, unit air conditioners, lithium chloride, testing, cooling, efficiency, experiment, comparing.


File Size : 1 file , 1.5 MB
Note : This product is unavailable in Russia, Belarus
Product Code(s) : D-16852
Published : 1995

History


Related products


Best-Selling Products

Alzheimer's Disease Report
Published Date: 12/01/2018
$2398.5
Cystic Fibrosis Disease Report
Published Date: 04/01/2019
$2398.5
Multiple Sclerosis Disease Report
Published Date: 12/01/2018
$2398.5
Non-Alcoholic Steatohepatitis Disease Report
Published Date: 12/01/2018
$2398.5
Non-Hodgkin's Lymphoma Disease Report
Published Date: 12/01/2018
$2398.5